Product image of Helen (Chlormadinone Acetate, Ethinylestradiol) supplied by GNH India

Helen

Active Ingredient:
Chlormadinone Acetate, Ethinylestradiol
Origin:
EU

Helen (Chlormadinone Acetate, Ethinylestradiol)

Chlormadinone acetate / Ethinylestradiol, the active ingredient in Helen, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy and helps regulate menstrual cycles in women of reproductive age.

GNH India supplies Helen as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ceres Pharma Nv

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Helen, a combined oral contraceptive, is used to manage reproductive hormone pathways.
  • Prevention of pregnancy: provides reliable contraceptive protection for women of childbearing potential.
  • Regulation of menstrual cycles: helps achieve more predictable bleeding patterns.
  • Management of hormone‑related menstrual disorders: reduces symptoms such as dysmenorrhea and menorrhagia.

How It Works

  • Helen combines chlormadinone acetate, a progestogen, with ethinylestradiol, an estrogen. The estrogen suppresses the hypothalamic‑pituitary‑ovarian axis, reducing the surge of luteinizing hormone that triggers ovulation, while the progestogen further inhibits follicular development. Together they thicken cervical mucus and alter the endometrial lining, creating conditions that prevent sperm penetration and implantation.

Side Effects

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: tension‑type or migraine‑like pain.
  • Breast tenderness: swelling or discomfort.
  • Weight gain: modest increase in body weight.
  • Mood changes: irritability or emotional fluctuations.
  • Spotting: irregular light bleeding.

Serious or Rare Side Effects

  • Venous thromboembolism: deep vein clot formation.
  • Pulmonary embolism: blockage of lung arteries.
  • Stroke: cerebrovascular accident.
  • Myocardial infarction: heart attack.
  • Severe allergic reaction: anaphylaxis or angioedema.
  • Hepatotoxicity: liver enzyme elevation or jaundice.

Precautions & Warnings

  • Before prescribing Helen, clinicians should evaluate individual risk factors and contraindications.
  • Assess cardiovascular risk: avoid use in women with a history of thromboembolic disorders.
  • Screen for liver disease: contraindicated in active liver disease.
  • Consider smoking status: do not use in women over 35 who smoke.
  • Review medication history: potential interactions with enzyme‑inducing drugs.
  • Pregnancy and lactation: discontinue if pregnancy is confirmed; not recommended while breastfeeding.
  • Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Avoid Interactions

Helen may interact with several medicines that affect hormone metabolism or clotting pathways.

Major Interactions (Avoid)

  • Strong CYP3A4 inducers (e.g., rifampicin, phenytoin): may markedly reduce contraceptive efficacy.
  • Protease inhibitors (certain antiretrovirals): can alter hormone levels and effectiveness.
  • St. John’s wort: may decrease plasma concentrations of the active hormones.

Moderate Interactions (Monitor Closely)

  • Antiepileptic drugs (e.g., carbamazepine): may require monitoring of contraceptive protection.
  • Anticoagulants: combined use may increase thrombotic risk.
  • Certain antibiotics (e.g., tetracycline): generally minimal effect but monitoring is advised.

Frequently Asked Questions

Helen is a combined oral contraceptive containing chlormadinone acetate and ethinylestradiol. It is prescribed to prevent pregnancy and to help regulate menstrual cycles in women of reproductive age.

The ethinylestradiol component suppresses the hypothalamic‑pituitary‑ovarian axis, preventing the luteinizing hormone surge that triggers ovulation. Chlormadinone acetate, a progestogen, further inhibits follicular development, thickens cervical mucus, and alters the endometrial lining, creating an environment that blocks sperm penetration and implantation.

The dosing regimen for Helen is determined by the prescribing healthcare professional. Typically, combined oral contraceptives are taken once daily, but the exact schedule and tablet strength must be set by the prescriber based on individual patient needs.

Helen is not intended for use during pregnancy; it should be discontinued if pregnancy is confirmed. Safety data for breastfeeding are limited, and the product is generally not recommended for nursing mothers unless the benefits outweigh potential risks as assessed by a clinician.

To order Helen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The team then replies with pricing, availability, shipping details and any required import documentation.

Helen contains chlormadinone acetate, a progestogen with a slightly higher anti‑androgenic profile compared with some other progestins, combined with ethinylestradiol. This may offer comparable contraceptive efficacy while providing additional benefits for acne or hirsutism in some users, though individual response varies.

Helen tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Helen is taken orally, usually as a single tablet each day at the same time. Patients should follow the prescribing information regarding the start of the cycle and any placebo or hormone‑free days included in the pack.

Serious risks include venous thromboembolism, pulmonary embolism, stroke, myocardial infarction, severe allergic reactions, and liver toxicity. Women with a history of clotting disorders, smoking over age 35, or certain cardiovascular conditions should avoid use.

Helen is contraindicated in women with known or suspected pregnancy, active liver disease, a history of thromboembolic events, uncontrolled hypertension, certain hormone‑sensitive cancers, or in smokers over 35 years of age. A thorough medical assessment is required before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Chlormadinone Acetate, Ethinylestradiol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT